These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 32421442

  • 1. Outcome and Late Complications of Hepatoblastomas Treated Using the Japanese Study Group for Pediatric Liver Tumor 2 Protocol.
    Hiyama E, Hishiki T, Watanabe K, Ida K, Ueda Y, Kurihara S, Yano M, Hoshino K, Yokoi A, Takama Y, Nogami Y, Taguchi T, Mori M, Kihira K, Miyazaki O, Fuji H, Honda S, Iehara T, Kazama T, Fujimura J, Tanaka Y, Inoue T, Tajiri T, Kondo S, Oue T, Yoshimura K.
    J Clin Oncol; 2020 Aug 01; 38(22):2488-2498. PubMed ID: 32421442
    [Abstract] [Full Text] [Related]

  • 2. Outcome of hepatoblastomas treated using the Japanese Study Group for Pediatric Liver Tumor (JPLT) protocol-2: report from the JPLT.
    Hishiki T, Matsunaga T, Sasaki F, Yano M, Ida K, Horie H, Kondo S, Watanabe K, Oue T, Tajiri T, Kamimatsuse A, Ohnuma N, Hiyama E.
    Pediatr Surg Int; 2011 Jan 01; 27(1):1-8. PubMed ID: 20922397
    [Abstract] [Full Text] [Related]

  • 3. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
    Häberle B, Bode U, von Schweinitz D.
    Klin Padiatr; 2003 Jan 01; 215(3):159-65. PubMed ID: 12778356
    [Abstract] [Full Text] [Related]

  • 4. Surgical strategies for unresectable hepatoblastomas.
    Tajiri T, Kimura O, Fumino S, Furukawa T, Iehara T, Souzaki R, Kinoshita Y, Koga Y, Suminoe A, Hara T, Kohashi K, Oda Y, Hishiki T, Hosoi H, Hiyama E, Taguchi T.
    J Pediatr Surg; 2012 Dec 01; 47(12):2194-8. PubMed ID: 23217875
    [Abstract] [Full Text] [Related]

  • 5. Outcome of hepatoblastoma treated with the JPLT-1 (Japanese Study Group for Pediatric Liver Tumor) Protocol-1: A report from the Japanese Study Group for Pediatric Liver Tumor.
    Sasaki F, Matsunaga T, Iwafuchi M, Hayashi Y, Ohkawa H, Ohira M, Okamatsu T, Sugito T, Tsuchida Y, Toyosaka A, Nagahara N, Nishihira H, Hata Y, Uchino J, Misugi K, Ohnuma N, (Japanese Study Group for Pediatric Liver Tumor).
    J Pediatr Surg; 2002 Jun 01; 37(6):851-6. PubMed ID: 12037748
    [Abstract] [Full Text] [Related]

  • 6. Improved survival outcome for hepatoblastoma based on an optimal chemotherapeutic regimen--a report from the study group for pediatric solid malignant tumors in the Kyushu area.
    Suita S, Tajiri T, Takamatsu H, Mizote H, Nagasaki A, Inomata Y, Hara T, Okamura J, Miyazaki S, Kawakami K, Eguchi H, Tsuneyoshi M, Committee for Pediatric Solid Malignant Tumors in the Kyushu Area, Japan.
    J Pediatr Surg; 2004 Feb 01; 39(2):195-8; discussion 195-8. PubMed ID: 14966739
    [Abstract] [Full Text] [Related]

  • 7. A cisplatin plus pirarubicin-based JPLT2 chemotherapy for hepatoblastoma: experience and future of the Japanese Study Group for Pediatric Liver Tumor (JPLT).
    Hiyama E, Ueda Y, Onitake Y, Kurihara S, Watanabe K, Hishiki T, Tajiri T, Ida K, Yano M, Kondo S, Oue T, Japanese Study Group for Pediatric Liver Tumor.
    Pediatr Surg Int; 2013 Oct 01; 29(10):1071-5. PubMed ID: 24026876
    [Abstract] [Full Text] [Related]

  • 8. Resectability and tumor response after preoperative chemotherapy in hepatoblastoma treated by the Japanese Study Group for Pediatric Liver Tumor (JPLT)-2 protocol.
    Hiyama E, Hishiki T, Watanabe K, Ida K, Yano M, Oue T, Iehara T, Hoshino K, Koh K, Tanaka Y, Kurihara S, Ueda Y, Onitake Y.
    J Pediatr Surg; 2016 Dec 01; 51(12):2053-2057. PubMed ID: 27712887
    [Abstract] [Full Text] [Related]

  • 9. Mortality and morbidity in primarily resected hepatoblastomas in Japan: Experience of the JPLT (Japanese Study Group for Pediatric Liver Tumor) trials.
    Hiyama E, Hishiki T, Watanabe K, Ida K, Yano M, Oue T, Iehara T, Hoshino K, Koh K, Tanaka Y, Kurihara S, Ueda Y, Onitake Y.
    J Pediatr Surg; 2015 Dec 01; 50(12):2098-101. PubMed ID: 26388131
    [Abstract] [Full Text] [Related]

  • 10. Treatment outcome and pattern of failure in hepatoblastoma treated with a consensus protocol in Hong Kong.
    Liu APY, Ip JJK, Leung AWK, Luk CW, Li CH, Ho KKH, Lo R, Chan EKW, Chan ACY, Chung PHY, Chiang AKS.
    Pediatr Blood Cancer; 2019 Jan 01; 66(1):e27482. PubMed ID: 30270490
    [Abstract] [Full Text] [Related]

  • 11. Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study.
    Zsiros J, Brugieres L, Brock P, Roebuck D, Maibach R, Zimmermann A, Childs M, Pariente D, Laithier V, Otte JB, Branchereau S, Aronson D, Rangaswami A, Ronghe M, Casanova M, Sullivan M, Morland B, Czauderna P, Perilongo G, International Childhood Liver Tumours Strategy Group (SIOPEL).
    Lancet Oncol; 2013 Aug 01; 14(9):834-42. PubMed ID: 23831416
    [Abstract] [Full Text] [Related]

  • 12. Minimal adjuvant chemotherapy for children with hepatoblastoma resected at diagnosis (AHEP0731): a Children's Oncology Group, multicentre, phase 3 trial.
    Katzenstein HM, Langham MR, Malogolowkin MH, Krailo MD, Towbin AJ, McCarville MB, Finegold MJ, Ranganathan S, Dunn S, McGahren ED, Tiao GM, O'Neill AF, Qayed M, Furman WL, Xia C, Rodriguez-Galindo C, Meyers RL.
    Lancet Oncol; 2019 May 01; 20(5):719-727. PubMed ID: 30975630
    [Abstract] [Full Text] [Related]

  • 13. Successful Treatment of Refractory or Relapsed Hepatoblastoma With Autologous Hematopoietic Stem Cell Transplantation in Children.
    Kim BK, Choi JY, Hong KT, Park HJ, Kang HJ.
    J Pediatr Hematol Oncol; 2024 Jul 01; 46(5):e265-e271. PubMed ID: 38830616
    [Abstract] [Full Text] [Related]

  • 14. [Strategy for the treatment of hepatoblastoma in children].
    Sasaki F.
    Nihon Geka Gakkai Zasshi; 2005 Jul 01; 106(7):427-30. PubMed ID: 16045186
    [Abstract] [Full Text] [Related]

  • 15. Multidisciplinary management of hepatoblastoma in children: Experience from a developing country.
    Shanmugam N, Scott JX, Kumar V, Vij M, Ramachandran P, Narasimhan G, Reddy MS, Kota V, Munirathnam D, Kelgeri C, Sundaram K, Rela M.
    Pediatr Blood Cancer; 2017 Mar 01; 64(3):. PubMed ID: 27781375
    [Abstract] [Full Text] [Related]

  • 16. Impact of postoperative complications on overall survival of patients with hepatoblastoma.
    Becker K, Furch C, Schmid I, von Schweinitz D, Häberle B.
    Pediatr Blood Cancer; 2015 Jan 01; 62(1):24-8. PubMed ID: 25251521
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94.
    Fuchs J, Rydzynski J, Von Schweinitz D, Bode U, Hecker H, Weinel P, Bürger D, Harms D, Erttmann R, Oldhafer K, Mildenberger H, Study Committee of the Cooperative Pediatric Liver Tumor Study Hb 94 for the German Society for Pediatric Oncology and Hematology.
    Cancer; 2002 Jul 01; 95(1):172-82. PubMed ID: 12115331
    [Abstract] [Full Text] [Related]

  • 19. The Role Of Surgical Treatment In The Multidisciplinary Therapy For Hepatoblastoma.
    Yada K, Ishibashi H, Mori H, Sato H, Shimada M.
    Hepatogastroenterology; 2014 May 01; 61(131):553-6. PubMed ID: 26176034
    [Abstract] [Full Text] [Related]

  • 20. Relapses in hepatoblastoma patients: clinical characteristics and outcome--experience of the International Childhood Liver Tumour Strategy Group (SIOPEL).
    Semeraro M, Branchereau S, Maibach R, Zsiros J, Casanova M, Brock P, Domerg C, Aronson DC, Zimmermann A, Laithier V, Childs M, Roebuck D, Perilongo G, Czauderna P, Brugieres L.
    Eur J Cancer; 2013 Mar 01; 49(4):915-22. PubMed ID: 23146961
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.